PBYI · ISSUER CIK 1401667
PUMA BIOTECHNOLOGY, INC.
Between Aug 1, 2026 and Oct 29, 2026, 2 PUMA BIOTECHNOLOGY, INC. insiders reported $0.00 of open-market purchases and $612K of sales on SEC Form 4.
↗2 insiders filed
Original Form 4 filings from Aug 1, 2026 to Oct 29, 2026. 2 of 2 sales were reported under a 10b5-1 plan.
$0.00Insider buying
$612KInsider selling
−$612KNet open-market
Sep 16, 2026Latest filing
| Ticker | Insider | Type | Owned | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Sep 16, 202621:13 | Sep 14, 2026 | PBYI | Director | S · Sell10b5-1 | $9.10 | −5,000 | 54,750 | -8% | −$46K | ||
| Sep 16, 202621:06 | Sep 14, 2026 | PBYI | Director | S · Sell10b5-1 | $9.12 | −62,150 | 56,700 | -52% | −$567K | ||
| Sep 16, 202621:06 | Sep 14, 2026 | PBYI | Director | M · Exercise10b5-1 | $2.93 | +50,000 | 118,850 | +73% | $147K |